
Emerging SME Services · BSE
Incorporated in 2013, Maharashtra-based Transpact Enterprises Limited is a biotechnology startup focused on developing innovative and affordable solutions for specially-abled individuals. The company primarily designs, develops, and distributes the Vestibulator, a therapeutic device created to address vestibular dysfunctions. The Vestibulator is a co-patented technology of Transpact Enterprises and IRCC-IIT Bombay, and the company holds a license from the Society for Innovation and Entrepreneurship, IIT Bombay, to commercialize the product. While the design and customization of the device are handled in-house with the help of advanced software, the manufacturing process is outsourced to third-party vendors. Transpact Enterprises is dedicated to continuous innovation to enhance its offerings and improve the quality of life for its users.
Price Band
₹130
Issue Size
₹1.35 Cr
Lot Size
1000 shares
GMP
Est. Listing
₹130
at current GMP
Subscribed
—
Open
26 Aug 2019
Close
28 Aug 2019
Allotment
3 Sep 2019
Refund
4 Sep 2019
Demat Credit
5 Sep 2019
Listing
5 Sep 2019
Overall Subscription
0.00x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 51,923 | — | 0.00x |
| Non-Institutional (NII / HNI) | 15,577 | — | 0.00x |
| Retail Individual (RII) | 36,346 | — | 0.00x |
| Total | 103,846 | 0 | 0.00x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 36 | 36 | 1.00x |
| HNIs (10L +) | 1 | 1 | 1.00x |
| HNIs (2-10L) | 1 | 1 | 1.00x |
| Total Applications | 38 | 38 | 1.00x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Transpact Enterprises Ltd is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹1.35 Crores. The shares are offered at a price band of ₹130 to ₹130 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,30,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Bigshare Services Pvt Ltd. Eligible allottees will receive credit of equity shares into their Demat accounts by 2019-09-05, while un-allotted funds or UPI block mandates will be released on 2019-09-04.
Currently, Transpact Enterprises Ltd IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹130 to ₹130 per equity share.
The retail lot size is 1000 shares requiring a minimum application amount of ₹1,30,000. Expected listing price is ₹130 per equity share.
The Transpact Enterprises Ltd IPO aggregate issue size is ₹1.35 Crores with an equity price band set at ₹130 to ₹130 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,30,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Bigshare Services Pvt Ltd) and the BSE status verification website on or around 2019-09-03. Investors can verify status using PAN card or application number.
Transpact Enterprises Ltd shares are scheduled to list on BSE on 2019-09-05.